Harvard Bioscience
(NASDAQ:HBIO)
$4.20
0[0.00%]
At close: Mar 27
$4.20
0[0.00%]
PreMarket: 4:00PM EDT
Consensus Rating1
Overweight
Highest Price Target1
$7.00
Lowest Price Target1
$4.00
Consensus Price Target1
$6.00

Harvard Bioscience Stock (NASDAQ:HBIO), Analyst Ratings, Price Targets, Predictions

Harvard Bioscience Inc has a consensus price target of $6, established from looking at the 6 latest analyst ratings. The last 3 analyst ratings were released from Benchmark, Benchmark, and Keybanc on June 22, 2023, April 26, 2023, and April 26, 2023. With an average price target of $7 between Benchmark, Benchmark, and Keybanc, there's an implied 66.67% upside for Harvard Bioscience Inc from these 3 analyst ratings.

Analyst Rating Summary1

Analyst Ratings
Feb
0
0
0
0
0
Jan
0
0
0
0
0
Dec 23
0
0
0
0
0
Nov 23
0
0
0
0
0
Oct 23
0
0
0
0
0
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Benchmark
Keybanc
Benchmark

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Harvard Bioscience

date
ticker
Buy Now
Company
Current price
Upside/Downside
Analyst Firm
Analyst & % Accurate
Price Target Change
Rating Change
Previous / Current Rating
Get Alert
06/22/2023HBIOBuy Now
Harvard Bioscience
$4.2066.67%Benchmark
Bruce Jackson
→ $7ReiteratesSpeculative Buy → Speculative BuyGet Alert
04/26/2023HBIOBuy Now
Harvard Bioscience
$4.2066.67%Benchmark
Bruce Jackson
$4 → $7MaintainsBuyGet Alert
04/26/2023HBIOBuy Now
Harvard Bioscience
$4.2066.67%Keybanc
Paul Knight
$5 → $7MaintainsOverweightGet Alert
03/10/2023HBIOBuy Now
Harvard Bioscience
$4.20-4.76%Benchmark
Kenneth Bruce
→ $4Reiterates → BuyGet Alert
11/09/2022HBIOBuy Now
Harvard Bioscience
$4.2019.05%Keybanc
Paul Knight
$7 → $5MaintainsOverweightGet Alert
08/05/2022HBIOBuy Now
Harvard Bioscience
$4.2066.67%Keybanc
Paul Knight
$10 → $7MaintainsOverweightGet Alert

FAQ

Q

What is the target price for Harvard Bioscience (HBIO)?

A

The latest price target for Harvard Bioscience (NASDAQ: HBIO) was reported by Benchmark on June 22, 2023. The analyst firm set a price target for $7.00 expecting HBIO to rise to within 12 months (a possible 66.67% upside). 3 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Harvard Bioscience (HBIO)?

A

The latest analyst rating for Harvard Bioscience (NASDAQ: HBIO) was provided by Benchmark, and Harvard Bioscience reiterated their speculative buy rating.

Q

When was the last upgrade for Harvard Bioscience (HBIO)?

A

There is no last upgrade for Harvard Bioscience.

Q

When was the last downgrade for Harvard Bioscience (HBIO)?

A

There is no last downgrade for Harvard Bioscience.

Q

When is the next analyst rating going to be posted or updated for Harvard Bioscience (HBIO)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Harvard Bioscience, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Harvard Bioscience was filed on June 22, 2023 so you should expect the next rating to be made available sometime around June 22, 2024.

Q

Is the Analyst Rating Harvard Bioscience (HBIO) correct?

A

While ratings are subjective and will change, the latest Harvard Bioscience (HBIO) rating was a reiterated with a price target of $0.00 to $7.00. The current price Harvard Bioscience (HBIO) is trading at is $4.20, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch